Cash & equivalents decreased 15.4%
Cash & equivalents changed -15.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -15.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed -6.1% from the comparable as-filed period.
Operating income changed -5.3% from the comparable as-filed period.
Debt changed +4.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory / revenue changed -188 basis points from the comparable as-filed period.
Operating margin changed +19 basis points from the comparable as-filed period.
Research & development changed +8.9% from the comparable as-filed period.
SBC / revenue changed +3 basis points from the comparable as-filed period.
Selling, general & administrative changed -5.9% from the comparable as-filed period.
Stock-based compensation changed +10.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.